Navis Bio is advancing translational medicine through AI-driven tools by building a robust knowledge base and analytics platform that integrates with large structured databases like CTTI's AACT, allowing seamless querying and summarization of clinical trial data using LLM interfaces—democratizing access and speeding insight generation.
Navis Bio harnesses OpenAI and cloud credits to power LLM agents on their platform. Their solution enables researchers to quickly identify therapeutic targets, patient populations, biomarkers, and trial design options without deep technical expertise. As highlighted in their CTTI case study, their AI tools translate plain-language questions into SQL queries, bridging the gap between raw data and strategic decisions in drug discovery.

Navis Bio

Navis Bio